Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Patheon 3Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Patheon 3Q

Revenues from commercial manufacturing operations were down 2% to $130.2 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 3Q


3Q Revenues: $163.3 million (-1%)

3Q Loss: $3.0 million (loss of $5.2 million in 3Q09)

YTD Revenues: $493.5 million (+3%)

YTD Loss: $2.4 million (loss of $4.9 million YTD09)

Comments: Revenues from commercial manufacturing operations were down 2% to $130.2 million. North American commercial revenues increased $5.3 million, or 9% due to improved production in PR and favorable foreign exchange. European commercial revenues were down $8.0 million or 11% due to reduced volumes in Bourgoin. Pharmaceutical Development Services were up 5% to $33.1 million. Loss in the quarter includes $6.1 million of costs associated with the closure of the Caguas facility.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters